6β,19-Bridged androstenedione analogs as aromatase inhibitors

Steroids

Volumn 74, Issue 12, 2009, Pages 884-889

  Komatsu, Sachiko ^a   Yaguchi, Ayaka ^a   Yamashita, Kouwa ^a   Nagaoka, Masao ^b   Numazawa, Mitsuteru ^a  

^a TOHOKU PHARMACEUTICAL UNIVERSITY   (Japan)

^b NIHON PHARMACEUTICAL UNIVERSITY   (Japan)

Author keywords

6 ,19 Cycloandrostenedione; 6 ,19 Epithioandrostenedione; 6 ,19 Epoxyandrostenedione; 6 ,19 Methanoandrostenedione; Aromatase inhibitor; Human placental microsomes

Indexed keywords

19 FORMYLANDROST 5 ENE 3 BETA,17 BETA YL DIACETATE; 19 HYDROXYANDROSTENEDIONE; 6 BETA 19 CYCLOANDROSTENEDIONE; 6 BETA,19 CYCLOANDROST 4 ENE 3,17 DIONE; 6 BETA,19 EPITHIOANDROST 4 ENE 3,17 DIONE; 6 BETA,19 EPOXYANDROST 4 ENE 3,17 DIONE; 6 BETA,19 EPOXYANDROSTENEDIONE; 6 BETA,19 METHANOANDROST 4 ENE 3,17 DIONE; ANDROSTENEDIONE; AROMATASE INHIBITOR; UNCLASSIFIED DRUG; AROMATASE; DRUG DERIVATIVE;

ARTICLE; DRUG SYNTHESIS; CHEMISTRY; ENZYMOLOGY; FEMALE; HUMAN; IC 50; METABOLISM; PLACENTA; PREGNANCY; SYNTHESIS;

ANDROSTENEDIONE; AROMATASE; AROMATASE INHIBITORS; FEMALE; HUMANS; INHIBITORY CONCENTRATION 50; PLACENTA; PREGNANCY;

EID: 69949185922     PISSN: 0039128X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.steroids.2009.06.001     Document Type: Article

References (40)

1. Thompson Jr. E.A., and Siiteri P.K. The involvement of human placental microsomal cytochrome P-450 in aromatization. J Biol Chem 249 (1974) 5373-5378
2. Kellis Jr. J., and Vickery L.E. Purification and characterization of human placental aromatase cytochrome P-450. J Biol Chem 262 (1987) 4413-4420
3. Yoshida N., and Osawa Y. Purification of human placental aromatase cytochrome P-450 with monoclonal antibody and its characterization. Biochemistry 30 (1991) 3003-3010
4. Meyer A.S. Conversion of 19-hydroxy-4-androstene-3,17-dione to estrone by endocrine tissue. Biochim Biophys Acta 17 (1995) 441-442
5. Arigoni D., Battaglia R., Akhtar M., and Smith T. Stereospecificity of oxidation at C-19 in oestrogen biosynthesis. J Chem Soc Chem Commun (1975) 185-187
6. 1H]-3β-hydroxy-androst-5-en-17-one by human placental aromatase. J Am Chem Soc 108 (1986) 1847-1852
7. Akhtar M., Calder M.R., Corina D.L., and Wright J.N. Mechanistic studies on C-19 demethylation in oestrogen biosynthesis. Biochem J 201 (1982) 569-580
8. 2. J Chem Soc Chem Commun (1976) 854-856
9. Bednarski P.J., and Nelson S.D. Dissociation of 19-hydroxy-, 19-oxo-, and aromatizing activities in human placental microsomes through the use of suicide substrate to aromatase. J Steroid Biochem 32 (1989) 309-316
10. 18 steroids. Biochemistry 7 (1968) 33-40
11. 2H]-androgens into oestrogens by human placental aromatase. Biochem J 268 (1990) 553-561
12. Brodie A.M.H. Aromatase inhibitors in the treatment of breast cancer. J Steroid Biochem Mol Biol 49 (1994) 281-287
13. Harper-Wynne C., and Dowsett M. Recent advances in the clinical application of aromatase inhibitors. J Steroid Biochem Mol Biol 76 (2001) 179-186
14. Howell A., Howell S.J., Clarke R., and Anderson E. Where do selective estrogen receptor modulators (SERMs) and aromatase inhibitors (AIs) now fit into breast cancer treatment algorithms?. J Steroid Biochem Mol Biol 79 (2001) 227-237
15. Lombardi P. Exemestane, a new steroidal aromatase inhibitor of clinical relevance. Biochim Biophys Acta 1587 (2002) 326-337
16. Numazawa M., and Oshibe M. 6-Alkyl- and 6-arylandrost-4-ene-3,17-diones as aromatase inhibitors. Synthesis and structure-activity relationships. J Med Chem 37 (1994) 1312-1319
17. Numazawa M., and Oshibe M. Further studies on 6-alkylandrost-4-ene-3,17-diones as aromatase inhibitors: elongation of the 6-alkyl chain. Steroids 60 (1995) 506-511
18. Numazawa M., Oshibe M., Yamaguchi S., and Tachibana M. Time-dependent inactivation of aromatase by 6-alkylandrosta-1,4-diene-3,17-diones. Effects of length and configuration of the 6-alkyl group. J Med Chem 39 (1996) 1033-1038
19. Numazawa M., Oshibe M., and Yamaguchi S. 6-Alkylandrosta-4,6-diene-3,17-diones and their 1,4,6-triene analogs as aromatase inhibitors. Steroids 62 (1997) 595-602
20. Tan L., Hrycay E.G., and Matsumoto K. Synthesis and properties of the epimeric 6-hydroperoxyandrostenediones, new substrates/inhibitors of human placental aromatase. J Steroid Biochem 19 (1983) 1329-1338
21. Numazawa M., Shelangouski M., and Nagaoka M. Probing the binding pocket of the active site of aromatase with 6-ether or 6-ester substituted androst-4-ene-3,17-diones and their diene and triene analogs. Steroids 65 (2000) 871-882
22. Marcotte P.A., and Robinson C.H. Synthesis and evaluation of 10β-substituted 4-estrene-3,17-diones as inhibitors of human placental microsomal aromatase. Steroids 39 (1982) 325-344
23. Wright N.J., Calder M.R., and Akhtar M. Steroidal C19 sulphur and nitrogen derivatives designed as aromatase inhibitors. J Chem Soc Chem Commun (1985) 1733
24. Bednarski J.J., Porubek D.J., and Nelson S.D. Thiol-containing androgens as suicide substrates of aromatase. J Med Chem 28 (1985) 775-779
25. Banting L., Nicholls P.J., Shaw M.A., and Smith H.J. Recent developments in aromatase inhibition as a potential treatment for oestrogen-dependent breast cancer. Prog Med Chem 26 (1989) 253-298
26. Johnston J.O. Aromatase inhibitors. Crit Rev Biochem Mol Biol 33 (1998) 375-405
27. Covey D.F. Aromatase inhibitors: specific inhibitors of oestrogen biosynthesis. In: Berg D., and Plempel M. (Eds). Sterol biosynthesis inhibitors (1988), Ellis Horwood Ltd., Chichester (England) 534-571
28. Vicent G.P., Monteserin M.C., Veleiro A.S., Burton G., Lantos C.P., and Galigniana M.D. 21-Hydroxy-6,19-oxidoprogesterone: a novel synthetic steroid with specific antiglucocorticoid properties in the rat. Mol Pharmacol 52 (1997) 749-753
29. A receptor activity of a 6,19-oxido analogue of pregnanolone. Bioorg Med Chem Lett 13 (2003) 343-346
30. Veleiro A.S., Pecci A., Monteserin M.C., Baggio R., Garland M.T., Lantos C.P., et al. 6,19-Sulfur-bridged progesterone analogues with antiimmunosuppressive activity. J Med Chem 48 (2005) 5675-5683
31. Joselevich M., Ghini A.A., and Burton G. 6,19-Carbon-bridged steroids. Synthesis of 6,19-methanoprogesterone. Org Biomol Chem 1 (2003) 939-943
32. Chenna P.H., Veleiro A.S., Sonego J.M., Ceballos N.R., Garland M.T., Baggio R.F., et al. Synthesis of 6,19-cyclopregnanes. Constrained analogues of steroid hormones. Org Biomol Chem 5 (2007) 2453-2457
33. Kalvoda J., Heusler K., Ueberwasser H., Anner G., and Wettstein A. Steroids. CXCVIII. 19-Norsteroids. 4. Reductive ether cleavage of 5α-halo-6β,19-epoxysteroids. Helv Chim Acta 46 (1963) 1361-1369
34. 5-ungesattigen 19-mesylocy-steroiden. Helv Chim Acta 155 (1962) 2615-2618
35. Barton D.H.R., and McCombie S.W. A new method for the deoxygenation of secondary alcohols. J Chem Soc, Perkin Trans I (1975) 1574-1585
36. Ryan K.J. Biological aromatization of steroids. J Biol Chem 234 (1959) 268-272
37. Siiteri P.K., and Thompson Jr. E.A. Human placental aromatase. J Steroid Biochem 6 (1975) 317-322
38. Grafit version 5.0.3 (2001), Erithacus Software Limited, Surrey, UK
39. Andersen N.H., Hadley S.W., Kelly J.D., and Bacon E.R. Intramolecular olefinic aldehyde Prins reactions for the construction of five-membered rings. J Org Chem 50 (1985) 4144-4151
40. Barton D.H.R., Jang D.O., and Jaszberenyi J.C. The invention of radical reactions. Part XXXI. Diphenylsilane: a reagent for deoxygenation of alcohols via their thiocarbonyl derivatives, deamination via isonitriles, and dehalogenation of bromo and iodo compounds by radical chain chemistry. Tetrahedron 49 (1993) 7193-7214